Browsing Tag
Danaher Corporation
8 posts
Danaher (DHR) unit IDBS expands a-tune partnership to connect preclinical research data
Danaher Corporation's IDBS is deepening its partnership with a-tune software AG to connect animal research operations with structured laboratory data, targeting fragmented preclinical workflows and the growing demand for traceable, AI-ready scientific information.
October 29, 2026
Beckman Coulter names Cat Jennings president as Danaher Diagnostics targets steadier growth
Beckman Coulter Diagnostics has appointed former Boston Scientific executive Catherine Jennings as president, giving her responsibility for a laboratory platform processing more than one million tests every hour. The leadership change comes as parent Danaher's Diagnostics business returns to stronger underlying growth outside volatile respiratory testing.
October 16, 2026
Why does Danaher (DHR) completing the Masimo acquisition matter for diagnostics and patient monitoring?
Find out how Danaher’s $9.9bn Masimo acquisition could reshape DHR’s diagnostics growth, medtech competition and investor sentiment.
June 10, 2026
A $180-a-share bet: Can Danaher Corporation turn Masimo into a diagnostics growth engine?
Danaher Corporation’s Masimo acquisition gains shareholder approval. Discover what it means for diagnostics strategy and future growth.
May 4, 2026
Can Danaher Corporation unlock new hospital economics with its $9.9bn Masimo Corporation bet?
Danaher Corporation to acquire Masimo Corporation for $9.9B in cash. Discover what this means for hospital diagnostics and investor strategy. Read more.
February 17, 2026
AmeriWater expands sterile processing ST108 portfolio with remote monitoring analytics
AmeriWater launches remote monitoring for its ST108 sterile processing water systems, helping hospitals simplify compliance and safeguard patient safety.
October 3, 2025
Danaher wraps up $5.7bn acquisition of Abcam to bolster life sciences segment
Danaher Corporation (NYSE: DHR), a renowned global science and technology innovator, has announced the completion of its acquisition…
December 7, 2023
Danaher to acquire US CDMO Aldevron for $9.6bn
Danaher Corporation has agreed to acquire Aldevron, a North Dakota-based manufacturer of plasmid DNA, mRNA, and recombinant proteins,…
June 19, 2021